Corporate News

2022

Polarean notes statement from Amphion Innovations

Oct 11, 2019, 06:56 AM by felicity.hopkins ICOM

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product, notes the announcement made today by its partner company, Amphion Innovations Plc ("Amphion") that the remainder of its 15,972,523 shares in Polarean have now been sold. As previously announced, Amphion's holding in Polarean shares was pledged as security against a loan facility and the shares were sold pursuant to this security arrangement.

Following this sale, Amphion no longer holds any shares in Polarean.

The full TR-1 disclosure is set out below.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS(to be sent to the relevant issuerandto the FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Polarean Imaging plc
1b. Please indicate if the issuer is a non-UK issuer(please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification(please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:
3. Details of person subject to the notification obligationiv
Name Amphion Innovations plc
City and country of registered office (if applicable)
4. Full name of shareholder(s)(if different from 3.)v
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reachedvi: October 8 2019
6.Date on which issuer notified (DD/MM/YYYY): October 8 2019
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A) % of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B) Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached 0% 114,438,600
Position of previous notification (if

 

applicable)

13.96%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of
shares

 

ISIN code (if possible)

Number of voting rightsix % of voting rights
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB008BVVT4H71 0 0%
SUBTOTAL 8. A 0 0%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument Expiration
datex
Exercise/
Conversion Periodxi
Number of voting rights that may be acquired if the instrument is exercised/converted. % of voting rights
SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument Expiration
datex
Exercise/
Conversion Periodxi
Physical or cash settlementxii Number of voting rights % of voting rights
SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation(please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii X
Fullchain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv(please add additional rows as necessary)
Namexv % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held

11. Additional informationxvi

Place of completion London, UK
Date of completion October 8 2019

 

Enquiries:

Polarean Imaging plc www.polarean.com/www.polarean-ir.com
Richard Hullihen, Chief Executive Officer Via Walbrook PR
Richard Morgan, Chairman
SP Angel Corporate Finance LLP Tel: +44 (0)20 3470 0470
David Hignell / Lindsay Mair / Jamie Spotswood (Corporate Finance)
Vadim Alexandre / Rob Rees (Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780
or[email protected]
Anna Dunphy / Paul McManus Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893

 

Load more comments
Comment by from

2021

Polarean notes statement from Amphion Innovations

Oct 11, 2019, 06:56 AM by felicity.hopkins ICOM

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product, notes the announcement made today by its partner company, Amphion Innovations Plc ("Amphion") that the remainder of its 15,972,523 shares in Polarean have now been sold. As previously announced, Amphion's holding in Polarean shares was pledged as security against a loan facility and the shares were sold pursuant to this security arrangement.

Following this sale, Amphion no longer holds any shares in Polarean.

The full TR-1 disclosure is set out below.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS(to be sent to the relevant issuerandto the FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Polarean Imaging plc
1b. Please indicate if the issuer is a non-UK issuer(please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification(please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:
3. Details of person subject to the notification obligationiv
Name Amphion Innovations plc
City and country of registered office (if applicable)
4. Full name of shareholder(s)(if different from 3.)v
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reachedvi: October 8 2019
6.Date on which issuer notified (DD/MM/YYYY): October 8 2019
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A) % of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B) Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached 0% 114,438,600
Position of previous notification (if

 

applicable)

13.96%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of
shares

 

ISIN code (if possible)

Number of voting rightsix % of voting rights
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB008BVVT4H71 0 0%
SUBTOTAL 8. A 0 0%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument Expiration
datex
Exercise/
Conversion Periodxi
Number of voting rights that may be acquired if the instrument is exercised/converted. % of voting rights
SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument Expiration
datex
Exercise/
Conversion Periodxi
Physical or cash settlementxii Number of voting rights % of voting rights
SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation(please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii X
Fullchain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv(please add additional rows as necessary)
Namexv % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held

11. Additional informationxvi

Place of completion London, UK
Date of completion October 8 2019

 

Enquiries:

Polarean Imaging plc www.polarean.com/www.polarean-ir.com
Richard Hullihen, Chief Executive Officer Via Walbrook PR
Richard Morgan, Chairman
SP Angel Corporate Finance LLP Tel: +44 (0)20 3470 0470
David Hignell / Lindsay Mair / Jamie Spotswood (Corporate Finance)
Vadim Alexandre / Rob Rees (Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780
or[email protected]
Anna Dunphy / Paul McManus Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893

 

Load more comments
Comment by from

2020

Polarean notes statement from Amphion Innovations

Oct 11, 2019, 06:56 AM by felicity.hopkins ICOM

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product, notes the announcement made today by its partner company, Amphion Innovations Plc ("Amphion") that the remainder of its 15,972,523 shares in Polarean have now been sold. As previously announced, Amphion's holding in Polarean shares was pledged as security against a loan facility and the shares were sold pursuant to this security arrangement.

Following this sale, Amphion no longer holds any shares in Polarean.

The full TR-1 disclosure is set out below.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS(to be sent to the relevant issuerandto the FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Polarean Imaging plc
1b. Please indicate if the issuer is a non-UK issuer(please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification(please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:
3. Details of person subject to the notification obligationiv
Name Amphion Innovations plc
City and country of registered office (if applicable)
4. Full name of shareholder(s)(if different from 3.)v
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reachedvi: October 8 2019
6.Date on which issuer notified (DD/MM/YYYY): October 8 2019
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A) % of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B) Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached 0% 114,438,600
Position of previous notification (if

 

applicable)

13.96%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of
shares

 

ISIN code (if possible)

Number of voting rightsix % of voting rights
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB008BVVT4H71 0 0%
SUBTOTAL 8. A 0 0%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument Expiration
datex
Exercise/
Conversion Periodxi
Number of voting rights that may be acquired if the instrument is exercised/converted. % of voting rights
SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument Expiration
datex
Exercise/
Conversion Periodxi
Physical or cash settlementxii Number of voting rights % of voting rights
SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation(please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii X
Fullchain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv(please add additional rows as necessary)
Namexv % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held

11. Additional informationxvi

Place of completion London, UK
Date of completion October 8 2019

 

Enquiries:

Polarean Imaging plc www.polarean.com/www.polarean-ir.com
Richard Hullihen, Chief Executive Officer Via Walbrook PR
Richard Morgan, Chairman
SP Angel Corporate Finance LLP Tel: +44 (0)20 3470 0470
David Hignell / Lindsay Mair / Jamie Spotswood (Corporate Finance)
Vadim Alexandre / Rob Rees (Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780
or[email protected]
Anna Dunphy / Paul McManus Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893

 

Load more comments
Comment by from

2019

Polarean notes statement from Amphion Innovations

11 October 2019

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product, notes the announcement made today by its partner company, Amphion Innovations Plc ("Amphion") that the remainder of its 15,972,523 shares in Polarean have now been sold. As previously announced, Amphion's holding in Polarean shares was pledged as security against a loan facility and the shares were sold pursuant to this security arrangement.

Following this sale, Amphion no longer holds any shares in Polarean.

The full TR-1 disclosure is set out below.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS(to be sent to the relevant issuerandto the FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Polarean Imaging plc
1b. Please indicate if the issuer is a non-UK issuer(please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification(please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:
3. Details of person subject to the notification obligationiv
Name Amphion Innovations plc
City and country of registered office (if applicable)
4. Full name of shareholder(s)(if different from 3.)v
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reachedvi: October 8 2019
6.Date on which issuer notified (DD/MM/YYYY): October 8 2019
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A) % of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B) Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached 0% 114,438,600
Position of previous notification (if

 

applicable)

13.96%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of
shares

 

ISIN code (if possible)

Number of voting rightsix % of voting rights
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB008BVVT4H71 0 0%
SUBTOTAL 8. A 0 0%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument Expiration
datex
Exercise/
Conversion Periodxi
Number of voting rights that may be acquired if the instrument is exercised/converted. % of voting rights
SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument Expiration
datex
Exercise/
Conversion Periodxi
Physical or cash settlementxii Number of voting rights % of voting rights
SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation(please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii X
Fullchain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv(please add additional rows as necessary)
Namexv % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held

11. Additional informationxvi

Place of completion London, UK
Date of completion October 8 2019

 

Enquiries:

Polarean Imaging plc www.polarean.com/www.polarean-ir.com
Richard Hullihen, Chief Executive Officer Via Walbrook PR
Richard Morgan, Chairman
SP Angel Corporate Finance LLP Tel: +44 (0)20 3470 0470
David Hignell / Lindsay Mair / Jamie Spotswood (Corporate Finance)
Vadim Alexandre / Rob Rees (Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780
or[email protected]
Anna Dunphy / Paul McManus Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893

 

2018

Polarean notes statement from Amphion Innovations

11 October 2019

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product, notes the announcement made today by its partner company, Amphion Innovations Plc ("Amphion") that the remainder of its 15,972,523 shares in Polarean have now been sold. As previously announced, Amphion's holding in Polarean shares was pledged as security against a loan facility and the shares were sold pursuant to this security arrangement.

Following this sale, Amphion no longer holds any shares in Polarean.

The full TR-1 disclosure is set out below.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS(to be sent to the relevant issuerandto the FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Polarean Imaging plc
1b. Please indicate if the issuer is a non-UK issuer(please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification(please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:
3. Details of person subject to the notification obligationiv
Name Amphion Innovations plc
City and country of registered office (if applicable)
4. Full name of shareholder(s)(if different from 3.)v
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reachedvi: October 8 2019
6.Date on which issuer notified (DD/MM/YYYY): October 8 2019
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A) % of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B) Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached 0% 114,438,600
Position of previous notification (if

 

applicable)

13.96%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of
shares

 

ISIN code (if possible)

Number of voting rightsix % of voting rights
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB008BVVT4H71 0 0%
SUBTOTAL 8. A 0 0%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument Expiration
datex
Exercise/
Conversion Periodxi
Number of voting rights that may be acquired if the instrument is exercised/converted. % of voting rights
SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument Expiration
datex
Exercise/
Conversion Periodxi
Physical or cash settlementxii Number of voting rights % of voting rights
SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation(please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii X
Fullchain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv(please add additional rows as necessary)
Namexv % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held

11. Additional informationxvi

Place of completion London, UK
Date of completion October 8 2019

 

Enquiries:

Polarean Imaging plc www.polarean.com/www.polarean-ir.com
Richard Hullihen, Chief Executive Officer Via Walbrook PR
Richard Morgan, Chairman
SP Angel Corporate Finance LLP Tel: +44 (0)20 3470 0470
David Hignell / Lindsay Mair / Jamie Spotswood (Corporate Finance)
Vadim Alexandre / Rob Rees (Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780
or[email protected]
Anna Dunphy / Paul McManus Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893

 

Investor Alert

Sign up for Email Alerts